Sean Salmon Named EVP & President Cardiovascular Portfolio; Continues as EVP & President Diabetes Operating Unit

Sean Salmon Named EVP & President Cardiovascular Portfolio; Continues as EVP & President Diabetes Operating Unit
News provided by
Share this article
Share this article
DUBLIN, Dec. 14, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT) announced today that Sean Salmon, Executive Vice President and President, Diabetes Operating Unit has been named Executive Vice President and President, Cardiovascular Portfolio effective January 1. Salmon will also continue to lead the Diabetes Operating Unit and continue to serve on the company's Executive Committee. He succeeds Mike Coyle, who will leave Medtronic effective December 31 to accept a CEO role of a publicly traded company.
"We owe Mike a debt of gratitude for his significant contributions to Medtronic," said Geoff Martha, Medtronic Chairman and Chief Executive Officer. "He's played a vital role in our Cardiovascular portfolio, including overseeing the development and launches of numerous disruptive and life-saving technologies. On behalf of the Board, I would like to thank Mike for his leadership and wish him every success."

Related Keywords

Ireland ,Dublin ,Marguerite Copel ,Sean Salmon ,Mike Coyle ,Geoff Martha ,Ryan Weispfenning ,Exchange Commission ,Medtronic Executive Committee ,Medtronic ,Executive Vice President ,Diabetes Operating Unit ,Cardiovascular Portfolio ,Medtronic Chairman ,Chief Executive ,Renal Denervation ,Cardiac Surgery ,Structural Heart ,Medtronic Diabetes ,Executive Committee ,ஐயர்ல்யாஂட் ,டப்ளின் ,சீன் சால்மன் ,மைக் கோய்ல் ,ஜியோஃப் மார்த்தா ,பரிமாற்றம் தரகு ,மெதிடிறோனிக் நிர்வாகி குழு ,மெதிடிறோனிக் ,நிர்வாகி துணை ப்ரெஸிடெஂட் ,நீரிழிவு நோய் இயங்குகிறது அலகு ,இருதய போர்ட்‌ஃபோலீயோ ,மெதிடிறோனிக் தலைவர் ,தலைமை நிர்வாகி ,இதய அறுவை சிகிச்சை ,கட்டமைப்பு இதயம் ,மெதிடிறோனிக் நீரிழிவு நோய் ,நிர்வாகி குழு ,